reports
Uniqa Insurance Group AG: 1 director
A director at Uniqa Insurance Group AG bought 2,368 shares at 9.500EUR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
Dassault Systèmes Intensifies the MEDIDATA Commitment to Patient Exper...
VELIZY-VILLACOUBLAY, France--(BUSINESS WIRE)-- (Euronext Paris: FR0014003TT8, DSY.PA) today announced its investment in , a leader in prescription digital therapeutics and software-enhanced drug therapies. The transaction advances Dassault Systèmes’ transformation of the patient experience in life sciences and healthcare through end-to-end technology solutions used across the healthcare ecosystem. The transaction strengthens the existing relationship between Dassault Systèmes’ MEDIDATA brand and Click Therapeutics, helping to improve patient engagement - post-trial through commercialization ...
Ipsen announces issuance of €500 million inaugural Rated Public Bond
Ipsen announces issuance of €500 million inaugural Rated Public Bond Transaction follows Investment Grade ratings assignment from both S&P and Moody’s PARIS, FRANCE, 19 March 2025 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today announced the successful completion of its inaugural Rated Public Bond of €500 million with a coupon of 3.875%, maturing in March 2032. Following the disclosure of the Investment Grade ratings with BBB- from S&P and Baa3 from Moody’s, both with a stable outlook, this transaction was very well received and largely oversu...
Ipsen annonce le succès de son émission obligataire inaugurale notée d...
Ipsen annonce le succès de son émission obligataire inaugurale notée d'un montant de 500 millions d'euros Cette transaction fait suite à l’attribution, par S&P et Moody’s, de notations de crédit ‘Investment Grade’ PARIS, FRANCE, 19 mars 2025 - Ipsen (Euronext: IPN; ADR: IPSEY), groupe biopharmaceutique mondial de spécialité, a annoncé aujourd'hui, le succès de son émission obligataire inaugurale notée de 500 millions d'euros, assortie d'un coupon de 3.875%, et arrivant à échéance en mars 2032. Cette transaction, lancée peu après l’attribution par S&P et Moody’s de notations de crédit ‘...
SkiStar AB Half-Year Report September 2024-February 2025
SkiStar AB Half-Year Report September 2024-February 2025 A GROWING NUMBER OF SATISFIED GUESTS, GOOD WINTER CONDITIONS AND GREAT INTEREST IN SKIING HOLIDAYS Second Quarter Net sales for the second quarter increased by SEK 157 million, 6 percent, to SEK 2,787 million (2,630).Operating profit/loss for the second quarter increased by SEK 135 million, 13 percent, to SEK 1,200 million (1,065).Capital gains from exploitation operations were included with SEK 18 million (-6).Cash flow from operating activities increased by SEK 66 million to SEK 1,422 million (1,356).Basic and diluted earnings p...
SkiStar AB halvårsrapport september 2024-februari 2025
SkiStar AB halvårsrapport september 2024-februari 2025 FLER NÖJDA GÄSTER, FINA VINTERFÖRHÅLLADEN OCH ETT STORT INTRESSE FÖR SKIDSEMESTER Andra kvartalet Nettoomsättningen för det andra kvartalet ökade med 157 MSEK till 2 787 MSEK (2 630), motsvarande 6 procent.Rörelseresultatet för det andra kvartalet uppgick till 1 200 MSEK (1 065), vilket är en ökning med 135 MSEK, motsvarande 13 procent.Rearesultat från exploateringsverksamheten ingick med 18 MSEK (-6).Kassaflödet från den löpande verksamheten uppgick till 1 422 MSEK (1 356), en ökning med 66 MSEK.Resultat per aktie före och efter ut...
Fawry For Banking Technology And Electronic Payment: 1 director
A director at Fawry For Banking Technology And Electronic Payment bought 300,000 shares at 0.000EGP and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's dir...
GURIT ANNOUNCES RE-SIGNING OF LONG-TERM SUPPLY CONTRACT FOR DEFENSE SE...
Gurit Holding AG / Key word(s): Agreement GURIT ANNOUNCES RE-SIGNING OF LONG-TERM SUPPLY CONTRACT FOR DEFENSE SECTOR 19.03.2025 / 06:45 CET/CEST Zurich, March 19, 2025 Gurit (SIX Swiss Exchange: GURN) is pleased to announce the re-signing of a long-term materials supply contract for high performance structures in the defense sector. This multi-year contract marks the continuation of the company’s long-standing partnership with United States Marine Inc. (USMI), a supplier to the USA Department of Defense. This agreement is expected to generate approximately 10 million CHF in...
Maridive & Oil Services: 1 director
A director at Maridive & Oil Services bought 500,000 shares at 0.000USD and the significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two yea...
Mena Tourism & Real Estate Investment: 1 director
Two Directors at Mena Tourism & Real Estate Investment bought/sold 665,463 shares at 0.000EGP. The significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ov...
Airesis SA: 1 director
A director at Airesis SA bought 9,937,767 shares at 0.090CHF and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...
Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents...
A director at Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents sold 303,441 shares at 0.000EGP and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all ...
Amicogen Inc: 4 directors
Two Directors at Amicogen Inc bought 9,040 shares at between 3,492.000KRW and 3,496.000KRW. The significance rating of the trade was 35/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over ...
- Lindsay Whipp
PSA: Enterprise Software: SMID-Cap IT Services Valuations-Growth Gap
PSA: Enterprise Software: SMID-Cap IT Services Valuations-Growth Gap Looking for opportunities in SMID-cap IT services and SaaS companies with significant gaps between valuations and growth among those well positioned for growth in a changing world.
- Felix Fischer
- Jayanth Kandalam
- Si Yong Ng
- Tanvi Arora
Lucror Analytics - Morning Views Europe
In today's Morning Views publication we comment on developments of the following high yield issuers: Recordati, Manuchar, Forvia (formerly Faurecia), EVOCA, Boparan, Alain Afflelou, Oriflame
DraftKings Inc: 1 director
A director at DraftKings Inc sold/sold after exercising options 105,554 shares at 37.621USD and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors o...
Cosmo Pharmaceuticals N.V.: 1 director
A director at Cosmo Pharmaceuticals N.V. bought 3,000 shares at 55.252CHF and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two y...
Galderma Group AG: 1 director
A director at Galderma Group AG sold 86,731 shares at 91.808CHF and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...
Santos Limited: 1 director
A director at Santos Limited bought 30,000 shares at 6.200USD and the significance rating of the trade was 65/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...
Plaza S.A.: 1 director
A director at Plaza S.A. sold 38,460 shares at 1,950.000CLP and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.